Veru Inc share price logo

Veru Inc Share Price

NASDAQ: VERU

Small Cap

$2.30

as on

Veru Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.27
    $2.33
    downward going graph

    1.30%

    Downside

    1.30%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.10
    $7.40
    downward going graph

    8.70%

    Downside

    221.74%

    Upside

    downward going graph

Veru Inc share price movements today

Previous Close
$2.30
Open
$2.30
Volume
136.5K
Day's Low - High
$2.27 - $2.33
52 Week Low - High
$2.10 - $7.40

Veru Inc Historical Returns

1 Month Return
-11.2 %
3 Month Return
-1.71 %
1 Year Return
-55.56 %
3 Year Return
-83.33 %
5 Year Return
-98.04 %

Veru Inc Stock Fundamentals & Key Indicators

Check Veru Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$36.4M

EPS (TTM)

-1.185

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.97

Industry PE ratio

2.2044

PEG Ratio

3.5994

EBITDA

-29.9M

Revenue (TTM)

16.9M

Profit Margin

0.00%

Return On Equity TTM

-60.25%

Veru Inc Stock Valuation

Track how Veru Inc P/E has moved over time to understand its valuation trends.

Veru Inc in the last 5 years

  • Overview

  • Trends

Lowest (-196.72x)

June 30, 2022

Today (-2.97x)

March 25, 2026

Industry (2.20x)

March 25, 2026

Highest (-4.08x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -2.97x

Veru Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veru Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Veru Inc image
Veru Inc
BUY$36.4M-98.04%-2.970.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Veru Inc Stock including INR - Dollar returns

The Veru Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Veru Inc investment value today

Current value as on today

₹54,028

Returns

₹45,972

(-45.97%)

Returns from Veru Inc Stock

₹55,513 (-55.51%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Veru Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Veru Inc. Average target price of $25

Veru Inc Share Price Target

Get share price movements and forecasts by analysts on Veru Inc.

What analysts predicted

90.8%UPSIDE

Target Price

$25

Current Price

$2.3

Analyzed by

9 Analysts

Target

$25.00

Veru Inc target price $25, a slight upside of 90.8% compared to current price of $2.3. According to 9 analysts rating.

Veru Inc Stock’s Investor Sentiment and Interest

Search interest for Veru Inc Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-15% versus previous 30 day period

Veru Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
3
-
4
3
6
-
-
-
0
-
Gross Profit
1
1
0
1
2
0
0
0
0
0
Operating Income
-11
-8
-9
-10
-8
-10
-8
-7
1
-5
EBITDA
-10
-
-9
-10
-7
-10
-9
-8
12
-5
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-7
-9
-10
-8
-1
-7
-7
1
-5
Income Tax Expense
0
-
0
0
0
-7
-
-
-
-
Net Income
-23
-8
-10
-10
-8
-8
-7
-7
1
-5
Net Profit Margin
-615.43%
0.00%
-242.45%
-277.42%
-128.15%
0.00%
0.00%
0.00%
588.31%
0.00%

Veru Inc Annual Profit & Loss

All numbers in Millions USD

Sep 2016
Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
22
13
15
31
42
61
39
16
16
-
Gross Profit
13
7
8
21
30
47
30
7
5
0
Operating Income
3
-8
-20
-6
-14
12
-83
-93
-36
-24
EBITDA
4
-8
-20
-5
-14
9
-83
-89
-36
-35
Interest Expense
3
2
2
4
4
4
4
2
0
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
2
-8
-23
-12
-20
4
-83
-92
-37
-15
Income Tax Expense
2
-1
0
0
-1
-3
0
0
0
-
Net Income
0
-6
-23
-12
-18
7
-83
-93
-37
-22
Net Profit Margin
1.56%
-48.42%
-150.89%
-37.79%
-44.55%
12.07%
-212.88%
-571.60%
-223.86%
0.00%

Veru Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-8
-10
-10
-8
-8
-7
-7
1
-5
Operating Cash Flow
-6
-5
-5
-4
-11
-7
-5
-5
-6
Investing Cash Flow
-
0
0
0
17
1
0
6
-
Financing Cash Flow
36
0
0
-
-4
-
-
23
23
Change in Cash
30
-5
-5
-4
1
-6
-5
0
17

Veru Inc Annual Cash Flow

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
-6
-23
-12
-18
7
-83
-93
-37
-22
Operating Cash Flow
0
-11
-5
-1
-15
-47
-88
-21
-30
Investing Cash Flow
0
0
0
0
14
4
6
0
25
Financing Cash Flow
12
12
8
9
109
1
11
36
-4
Change in Cash
0
0
2
7
108
-42
-70
15
-9

Global Institutional Holdings in Veru Inc

Funds
Holdings
Vanguard Group Inc
3.95%
Adage Capital Partners Gp LLC
0.68%
Envestnet Asset Management Inc
0.42%
Geode Capital Management, LLC
0.97%
Summit Financial, LLC
1.02%
See all

Insights on Veru Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 71.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Veru Inc has experienced a drawdown of -83.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 73.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, VERU stock has moved down by -55.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.65M → 247.06K (in $), with an average decrease of 96.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.45M → -5.33M (in $), with an average decrease of 466.9% per quarter

About Veru Inc

the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
OrganisationVeru Inc
Headquarters2916 North Miami Avenue, Miami, FL, United States, 33127
IndustryConsumer Non-Durables
CEODr. Mitchell S. Steiner F.A.C.S., M.D.
E-voting on sharesClick here to vote

Key Management of Veru Inc

Name

Title

Ms. Michele Greco CPA

CFO & Chief Administrative Officer

Mr. Samuel Fisch

Executive Director of Investor Relations & Corporate Communications

Dr. Domingo Rodriguez M.D.

Executive Vice President of Global Clinical Operations

Dr. Gary Bird Ph.D.

Executive Vice President of Quality & Regulatory Affairs

Dr. Mitchell S. Steiner F.A.C.S., M.D.

Chairman, President & CEO

Dr. K. Gary Barnette Ph.D.

Chief Scientific Officer

Mr. Kevin J. Gilbert CPA, J.D.

Executive Vice President of Corporate Development

Mr. Martin Tayler

Executive Vice President of FC2 Global Operations

Dr. Harry D. Fisch F.A.C.S., M.D.

Vice Chairman & Chief Corporate Officer

Mr. Philip R. Greenberg J.D.

Executive VP, General Counsel & Secretary

FAQs

What is Veru Inc share price today?

Veru Inc share price today is $2.3 as on at the close of the market. Veru Inc share today touched a day high of $2.33 and a low of $2.27.

What is the 52 week high and 52 week low for Veru Inc share?

Veru Inc share touched a 52 week high of $7.4 on and a 52 week low of $2.1 on . Veru Inc stock price today i.e. is closed at $2.3,which is 68.92% down from its 52 week high and 9.52% up from its 52 week low.

What is Veru Inc's market capitalisation today?

Veru Inc market capitalisation is $0.00T as on .

How to invest in Veru Inc Stock (VERU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Veru Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veru Inc Shares that will get you 0.6522 shares as per Veru Inc share price of $2.3 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Veru Inc Stock (VERU) from India?

Indian investors can start investing in Veru Inc (VERU) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Veru Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Veru Inc share’s latest price of $2.3 as on March 25, 2026 at 1:29 am IST, you will get 4.3478 shares of Veru Inc. Learn more about fractional shares .

What are the returns that Veru Inc has given to Indian investors in the last 5 years?

Veru Inc stock has given -98.04% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?